Drug Topics
DECEMBER 14, 2023
While either vaccine offers some protection, having both vaccines offers the strongest level of protection against hospitalization and severe complications like MIS-C, and death.
Pharmacy Is Right For Me
DECEMBER 14, 2023
An Unexpected Path Deciding exactly what you want to do or where you want to go in life is difficult. What if you don’t like where you end up? What if you change your mind? Dr. Stephen Small is a prime example of what it looks like to not only change your mind but to embrace the unexpected. Dr. Small is a pediatric clinical pharmacist specialist but if you had asked him years earlier, he would not have thought that he would end up working with children, “Pediatrics was actually the only specialt
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
DECEMBER 14, 2023
The mediterranean diet targets inflammation, oxidative stress, and hormonal balance mechanisms, which are also associated with female reproductive outcomes.
Pharmacy Times
DECEMBER 14, 2023
The approval carries the limitation that ritlecitinib should not be used in combination with biologic immunomodulators, cyclosporine, other Janus kinase inhibitors, or other potent immunosuppressants.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
DECEMBER 14, 2023
Pfizer’s $43 billion acquisition of Seagen is in the books, the company said on Thursda | It’s a done deal. Pfizer’s $43 billion acquisition of Seagen is in the books, as it becomes the largest M&A transaction in the biopharma industry since AbbVie snatched up Allergan for $63 billion in 2019. The buyout of the antibody-drug conjugate specialist has doubled Pfizer’s pipeline to 60 programs.
Pharmacy Times
DECEMBER 14, 2023
Feldman details her experience with C. diff, how the COVID-19 pandemic slowed the timeline of care, and how her surgical history and the use of antibiotics played into the disease’s onset.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
DECEMBER 14, 2023
The products include Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution, Icatibant Injection, Esomeprazole Magnesium Capsules, and Apremilast Tablets.
Fierce Healthcare
DECEMBER 14, 2023
A new price comparison study finds over 50% higher facility fees for commercially insured colonoscopies performed in hospitals rather than ambulatory surgery centers (ASCs), suggesting that “money | The analysis of commercial payers' price transparency data shows that “money has apparently been left on the table” for employers and consumers, the study's senior author says.
STAT
DECEMBER 14, 2023
In a bid toward greater transparency, the U.S. Food and Drug Administration earlier this month launched a dashboard containing preliminary notices sent to companies, universities, and researchers that failed to register clinical trials or report study results. The agency has so far sent about 120 so-called pre-notices indicating a clinical trial sponsor or investigator failed to comply with a federal law that requires such steps.
Pharmacy Times
DECEMBER 14, 2023
The update also removed the maximally tolerated qualifier for statin use and the statement that said morbidity and mortality was not yet determined.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
DECEMBER 14, 2023
WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry. Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.
Drug Topics
DECEMBER 14, 2023
Six posters presented at the 65th American Society of Hematology Annual Meeting and Exposition looked at how treatments are impacting care for this patient population.
STAT
DECEMBER 14, 2023
North Carolina’s attorney general alleges in a new lawsuit that HCA Healthcare is violating the terms of the agreement that allowed it to buy Mission Health, a formerly nonprofit health system. In the complaint filed Thursday , attorney general Josh Stein said HCA, the country’s largest for-profit hospital chain, is not providing the quality, consistent emergency and cancer care that it committed to delivering across Mission’s six western North Carolina hospitals.
Fierce Healthcare
DECEMBER 14, 2023
Oracle's second-quarter revenue fell short of analysts' expectations, dragged down by its Cerner business and slowing cloud growth. | Oracle is using its tech muscle to add new capabilities to the Millennium EHR, chairman Larry Ellison said. "We are going after a much larger market than Cerner was. We expect Cerner to be a growth story," he told investors during Oracle's Q2 earnings call.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
DECEMBER 14, 2023
Jay Bradner, a former top research leader at Novartis, is joining Amgen as its new chief scientific officer, the California company announced Thursday. Bradner is taking over for Amgen veteran David Reese in the role. Reese is becoming the company’s chief technology officer. “For more than 40 years, Amgen’s focus on innovation has enabled us to deliver life-changing medicines to patients suffering from serious diseases around the world,” Robert Bradway, Am
Drug Topics
DECEMBER 14, 2023
Pharmacy is positioned for growth like never before, and to meet this rapid increase, pharmacies must adopt innovative methods to keep up with the rising demand. Where do your pharmacists spend most of their time? If your answer is "counting pills," it might be time to dig deeper and ask yourself where you want them to be spending their time.
Fierce Healthcare
DECEMBER 14, 2023
The Biden administration is cracking down on pharmaceutical companies as part of its price-fighting measures under the Inflation Reduction Act. | The Biden Administration announced Thursday a list of 48 Part B drugs with prices that rose faster than the rate of inflation in the final quarter of 2023. Here's what they plan to do now.
Pharmacy Times
DECEMBER 14, 2023
This is the first FDA approval for a therapy intended to reduce the risk of relapse in patients with high-risk neuroblastoma.
Fierce Pharma
DECEMBER 14, 2023
Despite the high list price of Lyfgenia, bluebird has signed a large reimbursement deal for the sickle cell disease (SCD) gene therapy less than a week after its
Pharmacy Times
DECEMBER 14, 2023
The results found that the M2e nanoparticle injection could efficiently protect individuals from influenza A viruses.
STAT
DECEMBER 14, 2023
For years, Lauren Gavron relied on oxycodone to quiet the pain in her missing lower left limb. But she hated the fog that came with it, preventing her from feeling comfortable enough to drive. When researchers at the University of Pittsburgh delivered electric jolts to her spine in 2021, the Duquesne, Pennsylvania resident was shocked to feel that pain temporarily melt away — and to feel sensation in her prosthetic foot, improving her walk and balance.
Drug Store News
DECEMBER 14, 2023
The healthcare industry joined together Wednesday night in New York City to honor and celebrate NACDS’ 90th anniversary, while also paying tribute to pharmacy retailers.
STAT
DECEMBER 14, 2023
On Wednesday, the Supreme Court announced it will soon weigh in on a case that challenges how the Food and Drug Administration regulates mifepristone , a drug it approved almost 25 years ago that is used to terminate pregnancy. The case, the Alliance for Hippocratic Medicine v. FDA, is disguised as a dispute over safety. In reality, it’s about whether the courts will go along with overturning, for political reasons, the authority of the FDA as the scientific arbiter of approval of ne
European Pharmaceutical Review
DECEMBER 14, 2023
In the ever-evolving landscape of regulatory decisions, the quest for safeguarding public health remains paramount. Decisions to remove medicines from market are not taken lightly and are often based upon all evidence available to inform a benefit/risk balance. This evidence can come from a range of sources, such as randomised controlled trials (RCTs), observational studies, and spontaneous reporting.
STAT
DECEMBER 14, 2023
It’s no secret that the obesity epidemic in the United States has reached alarming levels, with rates surpassing 40% of the population. Despite a robust focus on wellness and exercise in the media, post-pandemic America continues to rank among the global leaders in obesity rates. Estimates indicate that treating obesity will be expensive, but those sums pale in comparison to the estimated direct and indirect costs of $1.7 trillion that obesity places on the U.S. health care system today.
Drug Store News
DECEMBER 14, 2023
Drug Store News held its 25th annual Industry Issues Summit in New York City on Dec. 13, where industry leaders weighed in on a myriad of challenges and opportunities.
Fierce Pharma
DECEMBER 14, 2023
While existing neuroblastoma treatments can help patients achieve remission, sustaining that remission has proven tricky. But now, patients and doctors have a new oral option. | The U.S. FDA has approved US WorldMeds’ Iwilfin—also known as eflornithine—as a new oral maintenance therapy for high-risk neuroblastoma. The drug, cleared in 192 mg tablets, is indicated to cut the risk of relapse in kids and adults with high-risk neuroblastoma who’ve had at least a partial response to prior treatment.
STAT
DECEMBER 14, 2023
Either American products are getting worse, or scrutiny over their safety is getting tougher. Whichever the case, product recalls by the Food and Drug Administration and the Consumer Product Safety Commission (CPSC) more than doubled between 2018 and 2022, according to new research published on Wednesday by life sciences software company MasterControl.
The Checkup by Singlecare
DECEMBER 14, 2023
If you’ve ever felt the painful symptoms of a urinary tract infection (UTI), it’s likely you want relief fast. You’re not alone—UTIs are common. They occur when bacteria like Escherichia coli (E. coli) infect the urinary tract organs, including the urethra (urethritis), bladder (cystitis), ureters, and kidneys (pyelonephritis). Most urinary tract infections are caused by bacteria and are treated with antibiotics.
PharmExec
DECEMBER 14, 2023
A discussion of the current standard for diabetes care and how the importance of patient centricity, including addressing patient's mental health, are imperative to the future of the space.
STAT
DECEMBER 14, 2023
Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question.
PharmExec
DECEMBER 14, 2023
JAMA Network study evaluates current attitudes toward individuals with acne with a call for pharma companies to focus efforts on helping to overcome these stigmas.
STAT
DECEMBER 14, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.
Pharmacy Times
DECEMBER 14, 2023
AFPs limit access to provider-prescribed specialty medications.
Expert insights. Personalized for you.
181 
Let's personalize your content